Overview
RUBY-3 and RUBY-4 are US-based studies by Alpine Immune Sciences who were looking for patient acquisition, study awareness and education. The phase 1 and 2 study explores the safety and potential effectiveness of an investigational drug, povetacicept (ALPN-303) for patients whose autoimmune kidney disease and autoimmune cytopenia conditions is not well controlled with their current medications.
Deliverables
- Digital Marketing
- Website Design & Development
- Creative & Content Solutions
- Research & Strategy
- Bespoke Reporting Dashboards
The challenge
The objectives of our work on RUBY-3 and RUBY-4, a US-based study by Alpine Immune Sciences were both patient acquisition and study awareness and education. The phase 1 and 2 study explores the safety and potential effectiveness of an investigational drug, povetacicept (ALPN-303) for patients whose autoimmune kidney disease is not well controlled with their current medications.
Ruby-3 is a decentralised clinical trial: the client is partnering with local clinics to host the trial rather than having a central clinic location.
The solution
Our solution included highly targeted advertising to specific patient groups which included people with IgAN, lupus nephritis, primary membranous nephropathy or anti-neutrophil cytoplasmic antibody associated vasculitis (AAV). By using targeted keywords on Google and display ads on Google Display Network, we have been able to ensure those actively seeking information about these diseases are made aware of the study. We also researched patient groups and the pages of established support communities on Meta and found a potential audience of 220,000 from this source alone.
Education was a vital part of our marketing solution. It is imperative that patients are fully informed about the conditions being treated and the treatment they will receive, but the scientific wording currently on the company’s website was not accessible. We ensured that our communications presented this information in a way that is easy to digest.
The outcome
The RUBY-3 and RUBY-4 trials achieved strong results through targeted campaigns that effectively connected with the right audiences. A significant number of participants completed the pre-screener, generating high-quality leads for the trials. Meta proved to be particularly successful in this campaign, thanks to the use of diverse creatives, tailored messaging, and in-depth profiling, which collectively ensured the campaign’s success.
20
Centers Recruiting Across the US
All information is correct at time of publishing (September 2024)
